Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0151 | 1 | 1 |
Brugia malayi | Pyridoxal-dependent decarboxylase conserved domain containing protein | 0.0111 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0151 | 1 | 0.5 |
Trypanosoma cruzi | sphingosine 1-phosphate lyase, putative | 0.0111 | 0 | 0.5 |
Leishmania major | sphingosine 1-phosphate lyase | 0.0111 | 0 | 0.5 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.0151 | 1 | 1 |
Trypanosoma cruzi | sphingosine 1-phosphate lyase, putative | 0.0111 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0151 | 1 | 1 |
Trypanosoma brucei | sphingosine 1-phosphate lyase, putative | 0.0111 | 0 | 0.5 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.0151 | 1 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0151 | 1 | 0.5 |
Schistosoma mansoni | sphingosine kinase A B | 0.0151 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.